Lyra Therapeutics Inc.
04/19/2024 | Press release | Distributed by Public on 04/19/2024 14:18
Management Change/Compensation - Form 8-K
| Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 15, 2024, Edward T. Anderson resigned from the Board of Directors (the "Board") of Lyra Therapeutics, Inc. (the "Company") as well as the Audit Committee and Compensation Committee of the Board. Mr. Anderson has been involved with the Company as an investor and adviser since 2006 and as a Board member since 2019. The Company thanks Mr. Anderson for his service and wishes him well in his future endeavors.
On April 15, 2024, the Board appointed Nancy L. Snyderman to the Audit Committee of the Board.